Associations between insurance-related affordable care act policy changes with HPV vaccine completion.

ABSTRACT:

Background

Although all 11- or 12-year-olds in the US were recommended to receive a 3-dose series of the human papillomavirus (HPV) vaccine within a 12-month period prior to 2016, rates of completion of the HPV vaccine series remained suboptimal. The effects of the Affordable Care Act (ACA), including private insurance coverage with no cost-sharing and health insurance expansions, on HPV vaccine completion are largely unknown. The aim of this study was to examine the associations between the ACA's 2010 provisions and 2014 insurance expansions with HPV vaccine completion by sex and health insurance type.

Methods

Using 2009-2015 public and private health insurance claims from Maine, New Hampshire, and Massachusetts, we identified 9-to-26-year-olds who had at least one HPV vacc

SUBMITTER: Hawkins SS 

PROVIDER: S-EPMC7866643 | biostudies-literature | 2021 Feb

REPOSITORIES: biostudies-literature